Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.

× No keyword cloud information.

9 in total

1. The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

Authors: E K Jeon; J Lim; M Kim; S-A Yahng; S-E Lee; B-S Cho; Y-J Kim; H-J Kim; C-K Min; S-G Cho; D-W Kim; J-W Lee; W-S Min; C-W Park; S Lee
Journal: Leukemia Date: 2010-11-12 Impact factor: 11.528

2. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

Authors: F van Rhee; A Hochhaus; F Lin; J V Melo; J M Goldman; N C Cross
Journal: Blood Date: 1996-06-15 Impact factor: 22.113

3. The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type.

Authors: R Bertorelle; L Bonaldi; E Bianchini; E Ramazzina; A Del Mistro; S Zamboni; L Chieco-Bianchi; R Paolini
Journal: Leukemia Date: 2001-12 Impact factor: 11.528

4. Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis.

Authors: Animesh Pardanani; Ayalew Tefferi; Mark R Litzow; Clive Zent; William J Hogan; Rebecca F McClure; David Viswanatha
Journal: Blood Date: 2009-10-15 Impact factor: 22.113

5. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.

Authors: J V Melo
Journal: Blood Date: 1996-10-01 Impact factor: 22.113

6. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

Authors: F Pane; F Frigeri; M Sindona; L Luciano; F Ferrara; R Cimino; G Meloni; G Saglio; F Salvatore; B Rotoli
Journal: Blood Date: 1996-10-01 Impact factor: 22.113

Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.

1. The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

2. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

3. The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type.

4. Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis.

5. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.

6. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

7. Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease?

8. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript.

Review 9. Chronic myelogenous leukemia, BCR-ABL1+.